Patients from 22+ countriesPlan your visit →
lutetium-therapy
Treatment Abroad · 31 Aug 2026

Why NET Patients from Malaysia and Singapore Travel to India for PRRT

Patients with gastroenteropancreatic neuroendocrine tumours in Malaysia and Singapore are increasingly travelling to India for PRRT - peptide receptor radionuclide therapy with lutetium Lu-177 dotatate. This guide explains what drives that decision, what the treatment costs, and how to plan a practical path to care.

Editorial oversight by Arpan Talwar·Founder, Art of Healing CancerUpdated 31 Aug 2026
Why NET Patients from Malaysia and Singapore Travel to India for PRRT

This article is for people with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) who live in Malaysia or Singapore, and for their families. If your oncologist has mentioned PRRT - peptide receptor radionuclide therapy using lutetium Lu-177 dotatate - but getting it locally feels hard or costly, this guide explains your options. It covers what PRRT involves, why access in Southeast Asia is limited, and how patients from both countries now travel to India for cheaper treatment.

What PRRT Is - and Who It Is For

PRRT is a targeted internal radiation therapy. The drug used for GEP-NETs is lutetium Lu-177 dotatate (brand name: Lutathera). It is a radioactive molecule that finds and binds to somatostatin receptors - proteins found on the surface of most GEP-NET cells. When it binds, the radiation damages tumour DNA from within, while surrounding healthy tissue gets a much lower dose.

The landmark NETTER-1 phase 3 trial, published in the New England Journal of Medicine, tested lutetium Lu-177 dotatate plus long-acting octreotide versus high-dose octreotide alone in patients with progressive midgut NETs. Median progression-free survival in the treatment group was not reached at the time of analysis, compared with 8.4 months in the control group - a hazard ratio of 0.21, meaning the treated group had about 79% lower risk of disease progression at that time. The response rate was 18% in the treatment group versus 3% in the control group. Based on this evidence, the US Food and Drug Administration approved lutetium Lu-177 dotatate in 2018 for somatostatin receptor-positive GEP-NETs.

To be eligible, your tumour must express somatostatin receptors - confirmed by a Ga-68 DOTATATE PET scan, which images those receptors across your whole body. Without adequate receptor uptake on this scan, PRRT is not recommended.

PRRT Availability in Malaysia and Singapore

Malaysia and Singapore both have nuclear medicine programs at major hospitals. Ga-68 DOTATATE PET imaging - the scan that shows if you can get PRRT - is available at some centers in both countries.

But delivering PRRT is harder. Hospitals need a steady supply of lutetium-177 radiopharmaceutical, a radiation-shielded suite, trained nuclear medicine doctors, and specialist nurses. Few Southeast Asian centers currently offer all of these.

In Singapore, some major hospitals may offer theranostic services, but Singapore's hospital costs rank among the highest in Asia-Pacific. In Malaysia, PRRT is available at some hospitals, but not all nuclear medicine departments that do diagnostic imaging also provide PRRT.

Patients in both countries often face the same barrier: their hospital doesn't offer PRRT, has long wait times, or charges more than they can afford.

How Does PRRT Cost Compare in India, Malaysia, and Singapore?

PRRT with lutetium Lu-177 dotatate - access and cost comparison across India, Malaysia, and Singapore (2025)
Factor India Malaysia Singapore
PRRT availability Available at multiple specialist nuclear medicine and cancer centres including Delhi, Mumbai, Hyderabad, Chennai, and Bangalore Available at a small number of tertiary hospitals; confirm current capacity directly with your preferred centre Available at selected major academic hospitals; contact directly to confirm current capacity and waiting time
Approx. cost per PRRT cycle - drug and administration (2025) Published tariffs from Delhi: approx. INR 2,50,000-4,00,000 per cycle (approx. USD 3,000-4,800) Not publicly listed - request a written itemised quote directly from the hospital before planning travel Not publicly listed - request a written itemised quote directly from the hospital before planning travel
Ga-68 DOTATATE PET eligibility scan Widely available; published tariffs approx. INR 25,000-40,000 (USD 300-480) Available at selected centres; can be done locally before travelling Available at major academic centres; can be done locally before travelling
Medical travel access to India India e-Medical Visa available online; straightforward for Malaysian and Singaporean nationals Malaysian nationals benefit from straightforward visa arrangements for India; confirm current requirements with the Indian High Commission Singaporean nationals travel to India visa-free; accompanying dependants may apply for an e-Medical Visa online

India per-cycle cost figures are based on published nuclear medicine tariff data from providers in Delhi. Costs vary by hospital, city, and clinical protocol. Malaysia and Singapore don't publish PRRT prices - always get a written, itemized quote from your chosen hospital before you travel or commit money. For reference: one dose of lutetium Lu-177 dotatate (Lutathera) in the United States costs about USD 55,896, so a four-dose course would be about USD 223,000 (Drugs.com, 2024). This US figure is for reference only; it does not reflect what insured American patients typically pay.

India's published per-cycle costs are far lower than US list prices. A full four-cycle PRRT course in India costs about USD 12,000-20,000 for drug and hospital fees - much less than the US cost. Malaysia and Singapore pricing falls somewhere between, but because it's not public, you can't easily compare your local options.

Why Patients from Malaysia and Singapore Choose India

Over the past decade, several major cancer centers in India have built strong nuclear medicine programs. Several practical reasons make India work for Southeast Asian patients seeking PRRT.

India makes its own lutetium-177 radiopharmaceuticals, so supply is stable and costs stay low. Several major centers have nuclear medicine teams that have treated many PRRT patients from around the world, including from Southeast Asia. Flights from Kuala Lumpur or Singapore to Indian cities are frequent, taking about four to six hours.

Before you travel, have a nuclear medicine team review your scans and pathology. You can send your scans to the Art of Healing Cancer team for review - they work with nuclear medicine doctors and can advise if PRRT matches your tumor type and scan results.

Step by Step: Accessing PRRT in India from Malaysia or Singapore

Getting to your first PRRT cycle in India involves several clear steps. Knowing them helps you plan and avoid delays.

  1. Get your Ga-68 DOTATATE PET scan at home. This scan uses a radioactive tracer to image somatostatin receptors across your body. It's the key document for PRRT eligibility. The Neuroendocrine Tumor Research Foundation explains what this scan involves and what the results mean. You can send your report and images digitally to an India PRRT center - you don't need to travel before starting the eligibility review.
  2. Request a remote eligibility review. Send your Ga-68 DOTATATE PET report, pathology grade, Ki-67 index, kidney and liver function tests, and treatment history to a PRRT center in India. Most major centers accept digital records through secure email or upload.
  3. Arrange your India e-Medical Visa. After you get a treatment offer or visa support letter from an Indian hospital, apply for the e-Medical Visa through the Indian government's online portal. Processing takes about 3 to 7 business days. Check current visa requirements with the Indian High Commission before you apply.
  4. Plan a 5 to 7 day trip per cycle. Nurses give PRRT slowly through an IV. You'll stay in a radiation-shielded room for 24 to 48 hours after for monitoring. Budget about one week per cycle, including blood tests, the infusion, and recovery.
  5. Return home between cycles. Cycles happen 6 to 8 weeks apart. You'll travel home between cycles for quality of life - and because your blood counts need to recover before the next dose. The short flight from Malaysia and Singapore makes this easy.
  6. Attend follow-up imaging after cycles 2 and 4. Your doctor usually checks how well PRRT worked with a post-therapy scan or repeat Ga-68 DOTATATE PET. This imaging typically happens during your cycle visits in India.

For details on your first eligibility appointment - what to bring and what tests happen - see our guide to your first PRRT consultation and screening appointment in India.

What to Expect During Your PRRT Course

PRRT with lutetium Lu-177 dotatate tends to cause fewer side effects than chemotherapy. You may get mild nausea and fatigue after each infusion, and your blood counts may temporarily drop - especially white blood cells and platelets. Your doctor will check your blood counts before the next cycle and may delay if you haven't recovered enough.

Traveling for treatment can affect your sleep and stress levels between cycles. Talk to your doctor about stress-management options while at home. Some patients use Ayurvedic supplements - see the options at Ayurnomics. Always discuss any supplement with your oncologist before starting it, especially during active treatment.

What If PRRT Is Not Suitable for You?

Not every GEP-NET patient qualifies for PRRT. You may not be eligible if your tumor has low somatostatin receptor expression on Ga-68 DOTATATE PET, severely reduced kidney function (since the kidneys clear lutetium-177 from your body), or high-grade disease (Grade 3, Ki-67 above 20%). If your initial review raises concerns, get a second opinion from another nuclear medicine center - interpretation can vary, and so can doctors' experience with PRRT.

Other treatments for GEP-NET patients who don't qualify for PRRT - like somatostatin analogues, everolimus, sunitinib, and trials - are covered in our article on GEP-NET therapy when PRRT isn't an option.

For an eligibility review before you travel, submit your scans through the Lutetium Therapy contact form. If PRRT isn't right for your situation, they'll tell you and can discuss other options for your tumor type and grade.

When to Talk to Your Doctor

Talk to your oncologist or a nuclear medicine specialist if your GEP-NET has progressed on somatostatin analogues, if you have a Ga-68 DOTATATE PET with positive receptors, or if you're thinking about PRRT but worry about access or cost. A remote eligibility review - where a nuclear medicine team examines your scans without you traveling - shows you your real options before you decide.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.

Frequently asked questions

Is PRRT with lutetium Lu-177 dotatate available in Malaysia or Singapore?

PRRT is available at a small number of specialist hospitals in both countries, but availability and waiting times vary. Not every nuclear medicine centre that performs Ga-68 DOTATATE PET imaging also administers PRRT. Contact major tertiary hospitals in your city directly to ask about their current program and waiting time. Many patients from Malaysia and Singapore find it more practical to travel to India, where multiple centres offer PRRT and published tariffs are significantly lower than in most other countries.

Do I need a Ga-68 DOTATATE PET scan before PRRT?

Yes. A Ga-68 DOTATATE PET scan is the standard imaging test used to confirm whether your tumour expresses enough somatostatin receptors for PRRT to be meaningful. If your scan shows low or absent receptor uptake, you may not be a candidate. This scan can usually be performed at home before you travel, and the report can be sent digitally to a PRRT centre in India for a remote eligibility review - so you can receive an expert opinion before booking any flights.

How many cycles of PRRT will I need and how long does the full course take?

The standard course of lutetium Lu-177 dotatate is four cycles, each given approximately 6 to 8 weeks apart. A full four-cycle course therefore spans roughly 6 to 9 months. Not every patient completes all four cycles - your oncology team will monitor your response and kidney function between cycles and may adjust the plan. Some patients receive fewer cycles if a particular concern arises, and some receive additional cycles in certain clinical circumstances.

Can I fly home between PRRT cycles?

Most patients do fly home between cycles, and this is generally permitted from a radiation safety standpoint after the initial monitored observation period following each infusion. Your nuclear medicine team will give you specific radiation precaution guidance before you leave hospital. Patients from Malaysia and Singapore are well-positioned for this arrangement - the flight from major Indian cities such as Delhi or Chennai to Kuala Lumpur or Singapore is typically 4 to 6 hours, and connections are frequent.

What happens if PRRT turns out not to be suitable for me?

If PRRT is not the right option based on your tumour grade, scan results, or kidney function, there are other treatment approaches for GEP-NETs to discuss with your oncologist. These may include somatostatin analogues such as octreotide or lanreotide, targeted therapies such as everolimus or sunitinib, and clinical trials. A remote eligibility review from a specialist nuclear medicine centre will typically include a clear explanation of alternatives if PRRT is not recommended for your specific situation. Seeking a second opinion from a different centre is always a reasonable step if you are uncertain about the initial assessment.

Have a specific question about your situation?

A free conversation with a patient navigator can help you understand whether Lutetium therapy fits your case, what questions to ask your oncologist, and which centers might be right for you.

Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.

PRRT for GEP-NET: India vs Malaysia and Singapore | lutetium-therapy